Holen Sie sich die Stockscreener-App
2.69
12.94%
-0.3999
Handel nachbörslich:
2.52
-0.17
-6.32%
Schlusskurs vom Vortag:
$3.0899
Offen:
$2.39
24-Stunden-Volumen:
4.45M
Relative Volume:
41.18
Marktkapitalisierung:
$34.21M
Einnahmen:
$2.47M
Nettoeinkommen (Verlust:
$-13.87M
KGV:
-2.2049
EPS:
-1.22
Netto-Cashflow:
$-12.42M
1W Leistung:
+5.49%
1M Leistung:
+2.67%
6M Leistung:
+4.26%
1J Leistung:
-45.82%
1-Tages-Spanne:
$2.2699
$2.80
1-Wochen-Bereich:
$2.2699
$3.18
52-Wochen-Spanne:
$1.31
$5.00
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Firmenname
Collplant Biotechnologies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CLGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.69 | 39.29M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-17 | Eingeleitet | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
Quantitative breakdown of CollPlant Biotechnologies Ltd. recent move2025 Market Trends & Real-Time Buy Zone Alerts - newser.com
Collplant stock plunges after advancing dermal filler to clinical trials - Investing.com
Collplant stock plunges after advancing dermal filler to clinical trials By Investing.com - Investing.com Canada
Multi factor analysis applied to CollPlant Biotechnologies Ltd.2025 Stock Rankings & Daily Momentum Trading Reports - newser.com
CollPlant advances photocurable dermal filler to clinical trials By Investing.com - Investing.com Australia
CollPlant advances photocurable dermal filler to clinical trials - Investing.com India
Light-Activated Dermal Filler Breakthrough: CollPlant's rhCollagen Tech Shows 1-Year Durability in Studies - Stock Titan
Tools to assess CollPlant Biotechnologies Ltd.’s risk profile2025 Geopolitical Influence & Long Hold Capital Preservation Tips - newser.com
Why CollPlant Biotechnologies Ltd. stock is trending among retail tradersLayoff News & Free Weekly Chart Analysis and Trade Guides - newser.com
CollPlant Biotechnologies Ltd. stock prediction for this weekJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
How to manage a losing position in CollPlant Biotechnologies Ltd.July 2025 Action & Pattern Based Trade Signal System - newser.com
United States 3D Printed Organ Market Set to Transform - openPR.com
Historical volatility pattern of CollPlant Biotechnologies Ltd. visualized2025 Price Momentum & Short-Term Trading Alerts - newser.com
Is CollPlant Biotechnologies Ltd. (CPT) stock suitable for passive index fundsEarnings Summary Report & Community Supported Trade Ideas - newser.com
Comparing CollPlant Biotechnologies Ltd. in custom built stock radarsJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Is FARO a good long term investmentMarket Sentiment Report & Breakout Portfolio Performance - earlytimes.in
What drives CollPlant Biotechnologies Ltd CPT stock priceSector Performance Review & Go Beyond the Headlines With Analyst Picks - earlytimes.in
Finanzdaten der Collplant Biotechnologies Ltd-Aktie (CLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):